Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7851502 Pharmaceutical formulations containing an SGLT2 inhibitor

Patent 7851502 was granted and assigned to Bristol-Myers Squibb on December, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Date Filed
March 21, 2008
Date of Patent
December 14, 2010
Patent Application Number
12053442
Patent Citations Received
‌
US Patent 11666590 Pharmaceutical composition, methods for treating and uses thereof
0
‌
US Patent 12115179 Pharmaceutical composition, methods for treating and uses thereof
0
‌
US Patent 11918596 Pharmaceutical composition, methods for treating and uses thereof
0
‌
US Patent 11660308 Pharmaceutical composition comprising dapagliflozin
0
‌
US Patent 11833166 Pharmaceutical composition, methods for treating and uses thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7851502
Patent Primary Examiner
‌
Shanon A. Foley

Find more entities like US Patent 7851502 Pharmaceutical formulations containing an SGLT2 inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.